Nutritional Outcomes in HPV ‐Associated Oropharyngeal Squamous Cell Carcinoma After Transoral Robotic Surgery
The Laryngoscope · 2025
DOI: 10.1002/lary.32264 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von Vera Bzhilyanskaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, University of Maryland, School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Oropharyngeal Neoplasms, Papillomavirus Infections, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Nutritional outcomes following transoral robotic surgery (TORS) for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma (OPSCC) are poorly understood. This study evaluates how TORS, with or without adjuvant treatment, impacts swallowing and weight loss.
Methods
All patients treated with TORS for HPV‐associated OPSCC from January 2016 to December 2023 were included. Weight loss, functional oral intake, feeding tube dependence, patient demographics, and treatment course were collected from patients' electronic medical records.
Results
In total, 160 patients with HPV‐associated OSPCC treated with TORS were included. 87.5% were male, with a median age of 60.0 years. Most patients were diagnosed with pT1 (53.8%) or pT2 (40.0%) and pN1 (78.1%) disease. 31.9% underwent TORS alone, while 42.5% received adjuvant radiation and 25.6% adjuvant chemoradiation. The median follow‐up time was 2.27 (range 0.26–7.56) years. 87.4% of patients underwent nasogastric tube placement during TORS. Prolonged postoperative nasogastric tube dependence was significantly associated with increased rates of feeding tube replacement ( p < 0.001; 95% CI, 1.051–1.181) later during treatment. Weight loss from three months to three years postoperatively was significantly greater in patients who received adjuvant radiation and chemoradiation ( p < 0.001), despite no significant difference in swallowing outcomes. There was no significant difference in weight loss between adjuvant radiation and chemoradiation groups.
Conclusions
Adjuvant treatment following TORS is associated with significantly greater long‐term weight loss but does not significantly alter swallowing outcomes. Longer duration of nasogastric tube dependence in the postoperative period is associated with higher rates of enteral feeding dependence later in treatment. Level of Evidence 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
- Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Vera Bzhilyanskaya, Jane Y Tong, Kyle M Hatten
Zitieren
APA
Bzhilyanskaya, V., Tong, J. Y., Ferris, M. J., Molitoris, J. K., & Hatten, K. M. (2025). Nutritional Outcomes in HPV ‐Associated Oropharyngeal Squamous Cell Carcinoma After Transoral Robotic Surgery. The Laryngoscope. https://doi.org/10.1002/lary.32264
Vancouver
Bzhilyanskaya V, Tong JY, Ferris MJ, Molitoris JK, Hatten KM. Nutritional Outcomes in HPV ‐Associated Oropharyngeal Squamous Cell Carcinoma After Transoral Robotic Surgery. The Laryngoscope. 2025. doi:10.1002/lary.32264
BibTeX
@article{Bzhilyanskaya2025,
author = {Bzhilyanskaya, Vera and Tong, Jane Y and Ferris, Matthew J and Molitoris, Jason K and Hatten, Kyle M},
title = {Nutritional Outcomes in HPV ‐Associated Oropharyngeal Squamous Cell Carcinoma After Transoral Robotic Surgery},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.32264}
}
EUVIMED